Signal Point Asset Management, LLC Pacira Bio Sciences, Inc. Transaction History

Signal Point Asset Management, LLC

  • $329 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 30, 2020
SELL
$36.31 - $46.83 $265,825 - $342,842
-7,321 Closed
0 $0
Q3 2019

Oct 18, 2019
SELL
$35.66 - $44.99 $111,223 - $140,323
-3,119 Reduced 29.88%
7,321 $279,000
Q2 2019

Aug 13, 2019
BUY
$36.57 - $47.97 $381,790 - $500,806
10,440 New
10,440 $454,000

Others Institutions Holding PCRX

# of Institutions
287
Shares Held
48.7M
Call Options Held
156K
Put Options Held
623K
View Full List

About Pacira BioSciences, Inc.

PCRX Quotes by TradingView
  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $965M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Signal Point Asset Management, LLC Portfolio

Follow Signal Point Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signal Point Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signal Point Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email